(Q39714121)

14 September 2017

title

Tumor-infiltrating IL-17-producing gammadelta T cells support the progression of tumor by promoting angiogenesis (English)

1 reference

14 September 2017

1 reference

Yoichiro Iwakura

3

0 references

author name string

Daiko Wakita

1

1 reference

14 September 2017

Kentaro Sumida

2

1 reference

14 September 2017

Hiroyoshi Nishikawa

4

1 reference

14 September 2017

Takayuki Ohkuri

5

1 reference

14 September 2017

Kenji Chamoto

6

1 reference

14 September 2017

Hidemitsu Kitamura

7

1 reference

14 September 2017

Takashi Nishimura

8

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

European Journal of Immunology

14 September 2017

published in

1 reference

14 September 2017

volume

40

1 reference

14 September 2017

issue

7

1 reference

14 September 2017

page(s)

1927-1937

1 reference

Immunosuppressive networks in the tumour environment and their therapeutic relevance

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

Angiogenesis as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

IL-6-dependent spontaneous proliferation is required for the induction of colitogenic IL-17-producing CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

The biological functions of T helper 17 cell effector cytokines in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

The critical role of type-1 innate and acquired immunity in tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

IFN-gamma-dependent type 1 immunity is crucial for immunosurveillance against squamous cell carcinoma in a novel mouse carcinogenesis model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

An essential role of antigen-presenting cell/T-helper type 1 cell-cell interactions in draining lymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

Th1 cell adjuvant therapy combined with tumor vaccination: a novel strategy for promoting CTL responses while avoiding the accumulation of Tregs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

IL-23 promotes tumour incidence and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

Interferons, immunity and cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

Gamma delta T cells provide an early source of interferon gamma in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

Regulation of cutaneous malignancy by gammadelta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

Paradoxical roles of the immune system during cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

Cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

Immune Enhancement of Skin Carcinogenesis by CD4+ T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

The distinct contributions of murine T cell receptor (TCR)gammadelta+ and TCRalphabeta+ T cells to different stages of chemically induced skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

Characterizing tumor-promoting T cells in chemically induced cutaneous carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

Antagonistic roles of CD4+ and CD8+ T-cells in 7,12-dimethylbenz(a)anthracene cutaneous carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

CD27 is a thymic determinant of the balance between interferon-gamma- and interleukin 17-producing gammadelta T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

T helper 17 cells promote cytotoxic T cell activation in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

Type 17 CD8+ T cells display enhanced antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

Tumor-specific Th17-polarized cells eradicate large established melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

Expression of IL-17 mRNA in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

7 January 2021

Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

7 January 2021

Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

7 January 2021

CCR6 and NK1.1 distinguish between IL-17A and IFN-γ-producing γδ effector T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940157

7 January 2021

Identifiers

DOI

10.1002/EJI.200940157

1 reference

release_nkxmdym3ffftjcmawrlft4jndy

14 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nkxmdym3ffftjcmawrlft4jndy

24 November 2022

mapped directly with Wikidata item

1 reference